Tuesday, 02 January 2024 12:17 GMT

Medical Imaging Market To Reach $70.8 Billion By 2033: Key Trends And Growth Forecast


(MENAFN- IMARC Group) Market Overview:

The medical imaging market is experiencing rapid growth, driven by Growing Burden of Chronic and Age-Related Diseases, Expansion of Government-Funded Health Infrastructure and Technological Advancements in Imaging Modalities. According to IMARC Group's latest research publication,“ Medical Imaging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033 “, The global medical imaging market size reached USD 44.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 70.8 Billion by 2033, exhibiting a growth rate (CAGR) of 5.03% during 2025-2033.

This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis.

Claim Your Free“Medical Imaging Market” Insights Sample PDF

Our Report Includes:

  • Market Dynamics
  • Market Trends And Market Outlook
  • Competitive Analysis
  • Industry Segmentation
  • Strategic Recommendations

Growth Factors in the Medical Imaging Industry:

  • Growing Burden of Chronic and Age-Related Diseases

The rising incidence of chronic conditions-like cancer, cardiovascular disease, and neurological disorders-is one of the biggest forces behind the growing demand for medical imaging. As global populations age, the need for regular and accurate diagnostic tools has skyrocketed. For example, the World Health Organization notes that cardiovascular diseases remain the leading cause of death globally, and timely imaging is essential for early intervention. Additionally, cancer diagnostics heavily rely on imaging modalities such as CT, MRI, and PET scans to detect and monitor tumors. Countries with aging populations, such as Japan and Germany, are seeing increased adoption of advanced imaging technologies in both hospitals and outpatient clinics. Healthcare providers are investing in more efficient radiology workflows and AI-enabled platforms that help detect anomalies faster, supporting better outcomes. All of this points to a medical ecosystem where imaging is no longer optional-it's foundational to chronic care management.

  • Expansion of Government-Funded Health Infrastructure

Many governments are ramping up investment in healthcare infrastructure, particularly in emerging markets, which is driving imaging system demand. For instance, India's Ayushman Bharat Digital Mission and China's“Healthy China 2030” policy include major funding allocations to expand diagnostics capacity across urban and rural centers. This includes the deployment of CT scanners, digital X-rays, and ultrasound systems in district hospitals and community health centers. Additionally, public-private partnerships are being formed to modernize radiology services and improve access to early disease detection. These moves are not just about equipment installation-they're about improving equity in diagnostics. More people can now access imaging without having to travel to Tier 1 cities. In Europe and North America, similar government stimulus packages for hospital upgrades have also accelerated the replacement cycle of legacy imaging systems, boosting demand for compact, cloud-connected machines. Overall, government push is fueling both adoption and innovation in this space.

  • Technological Advancements in Imaging Modalities

Innovation in imaging hardware and software is playing a central role in market growth. Manufacturers are continuously developing systems that offer faster image acquisition, higher resolution, and lower radiation exposure. For instance, modern MRI machines now come with reduced noise levels and faster scanning protocols, improving both patient comfort and diagnostic accuracy. Companies like Siemens Healthineers and GE Healthcare are introducing AI-powered solutions that automate scan interpretation and flag abnormalities in real time. One standout innovation is the rise of portable imaging devices, such as handheld ultrasounds, which are transforming point-of-care diagnostics in emergency and primary care settings. On top of that, hybrid systems that combine PET/CT or SPECT/CT are gaining popularity for oncology and cardiac imaging, as they provide more comprehensive views in a single scan. These tech advances are making imaging more accessible, more accurate, and ultimately more impactful in clinical decision-making.

Key Trends in the Medical Imaging Market:

  • Surge in AI-Powered Diagnostic Tools

AI is rapidly becoming a cornerstone of medical imaging, enhancing everything from scan acquisition to diagnosis and reporting. Radiology departments are using AI algorithms to detect anomalies-such as lung nodules or brain lesions-faster and with fewer false positives. For example, AI-based tools are now capable of reading chest X-rays within seconds, helping triage cases in high-volume settings. Companies like Aidoc and Qure.ai are integrating their software into radiology workflows, and hospitals are reporting significant improvements in turnaround time. AI is also being used for image reconstruction, allowing for better image quality at lower doses of radiation. With cloud integration, radiologists can collaborate in real time or review flagged images remotely, speeding up diagnoses. This is particularly valuable in rural or under-resourced settings, where specialist availability is limited. Overall, AI is helping scale imaging services without compromising quality-making it one of the most transformative forces in the industry.

  • Increasing Demand for Point-of-Care Imaging

Point-of-care imaging is gaining serious momentum, particularly in emergency departments, intensive care units, and outpatient clinics. Portable ultrasound and compact X-ray systems are now common tools in bedside assessments, allowing faster diagnosis without moving patients. This is especially beneficial for trauma patients or those in critical care. For instance, handheld ultrasound devices like the Butterfly iQ are being widely adopted by primary care physicians and emergency responders for real-time cardiac, abdominal, or obstetric evaluations. In rural areas or mobile clinics, these tools are proving essential in bridging the diagnostic gap. The pandemic also accelerated this trend, as clinicians sought touchless and mobile diagnostic options to reduce exposure. With better battery life, wireless connectivity, and user-friendly interfaces, point-of-care devices are not just supplementing traditional imaging-they're reshaping the frontlines of diagnostic medicine.

  • Growing Integration of Imaging with Electronic Health Records (EHRs)

One of the more subtle but important trends in medical imaging is the integration of imaging systems with electronic health records. Seamless data flow between imaging platforms and patient records improves both operational efficiency and clinical decision-making. Clinicians can now access, compare, and annotate images directly within patient portals, reducing redundancy and improving diagnostic timelines. Leading PACS (Picture Archiving and Communication Systems) providers are building APIs that allow for real-time EHR integration, making it easier to view historical imaging data during current assessments. Hospitals using integrated systems have reported shorter radiology report cycles and fewer follow-up visits due to miscommunication. This interoperability is also key for remote consultations and second opinions, especially as telehealth becomes more embedded in care delivery. Imaging no longer exists in a silo-it's becoming part of a broader, data-driven healthcare ecosystem that supports faster and smarter treatment decisions.

Leading Companies Operating in the Global Medical Imaging Industry:

  • Canon Medical Systems Corporation (Canon Inc.)
  • Carestream Health
  • Cubresa Inc.
  • Esaote SpA
  • FUJIFILM VisualSonics Inc.
  • GE HealthCare (General Electric Company)
  • Hologic Inc.
  • Koning Corporation
  • Koninklijke Philips N.V.
  • Materialise NV
  • Mindray Medical International Limited
  • Samsung Medison Co. Ltd. (Samsung Electronics Co. Ltd.)
  • Siemens Healthineers AG (Siemens AG)

Medical Imaging Market Report Segmentation:

By Product:

  • CT Scanners
  • X-Ray Imaging Systems
  • MRI Systems
  • Ultrasound Imaging Systems
  • Nuclear Imaging Systems
  • Mammography Systems

X-ray imaging systems hold the biggest market share due to their widespread use, cost-effectiveness, and essential role in diagnosing a variety of medical conditions.

By Application:

  • Obstetrics and Gynecology Health
  • Orthopedics and Musculoskeletal
  • Neuro and Spine
  • Cardiovascular and Thoracic
  • General Imaging
  • Breast Health
  • Others

Cardiovascular and thoracic account for the majority of the market share because these areas have a high prevalence of chronic diseases requiring frequent and detailed imaging for accurate diagnosis and treatment.

By End User:

  • Hospitals
  • Diagnostic Centers
  • Academic Institutes and Research Organizations

Hospitals represent the largest segment as primary healthcare facilities equipped with advanced imaging technologies and cater to a large patient base.

Regional Insights:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

North America's dominance in the medical imaging market is attributed to its well-established healthcare infrastructure, high healthcare expenditure, and investments in advanced imaging technologies.

Research Methodology:

The report employs a comprehensive research methodology, combining primary and secondary data sources to validate findings. It includes market assessments, surveys, expert opinions, and data triangulation techniques to ensure accuracy and reliability.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

About Us:

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales[@]imarcgroup.com

Tel No:(D) +91 120 433 0800

United States:+1–201971–6302

MENAFN01082025004122016232ID1109871634



IMARC Group

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search